Case reportUse of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum
Under a Creative Commons license
open access
Key words
chronic myeloid leukemia
cutaneous adverse event
erythema nodosum
etanercept
tyrosine kinase inhibitor
Abbreviations used
CML
chronic myeloid leukemia
EN
erythema nodosum
TKI
tyrosine kinase inhibitors
TNF
tumor necrosis factor
Cited by (0)
Funding sources: None.
Conflicts of interest: None disclosed.
© 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.